| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0082 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |